Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain.
Off-label use of testosterone is allowed in the United States although the FDA has not approved this treatment for low sexual function or hypoactive sexual desire disorder particularly in postmenopausal women who experience surgery induced menopause.
Read the rest of this entry »
January 4th, 2009 | Posted in Breast Cancer, News | Tags: bedroom, cancer, crazy, drives, patch, risk, Testosterone, uncertain, Women
The trial of Procter & Gamble’s Intrinsa testosterone patches for women was sponsored by Procter & Gamble and the treatment was indicated for hypoactive sexual desire disorder (HSDD).
“HSDD is characterized as a lack or absence of sexual fantasies and desire for sexual activity for some period of time”, Wikipedia states. An estimated 26.7% among premenopausal women and 52.4% among naturally menopausal women had the condition, according to another study published in the July 2008 issue of Archives of Internal Medicine.
Read the rest of this entry »
January 4th, 2009 | Posted in Breast Cancer | Tags: bedroom, crazy, drives, Hormone, Male, Study, Women